Medical Devices

  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic to cut 81 employees at California diabetes site

    As Medtronic prepares to spin out its diabetes business, a spokesperson said the company is considering the structure, capabilities and scale needed to succeed.

    By • Feb. 20, 2026
  • Medtronic's Symplicity Spyral device is shown against a white background.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic’s blood pressure device wins coverage nod in Japan

    Medtronic is investing in the rollout of the Symplicity Spyral renal denervation procedure, including hiring for new market development roles, CEO Geoff Martha said on an earnings call.

    By • Feb. 20, 2026
  • the FDA Headquarters Explore the Trendline➔
    Image attribution tooltip
    Sara Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • A black reader is shown on top of a phone with a blood glucose reading.
    Image attribution tooltip
    Permission granted by Senseonics
    Image attribution tooltip

    Senseonics launches automated insulin dosing system with 1-year CGM

    The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes. 

    By • Feb. 20, 2026
  • Two black, rounded devices next to each other give the same reading of 102 mg/dL.
    Image attribution tooltip
    Courtesy of Trividia Health
    Image attribution tooltip

    FDA issues early alert on Trividia glucometer issue linked to 114 injuries

    Users may receive an error code either due to a test strip error or a very high blood glucose event, Trividia Health said.

    By • Feb. 19, 2026
  • A phone screen says "possible hypertension", and a watch next to the phone displays the same message.
    Image attribution tooltip
    Courtesy of Apple
    Image attribution tooltip

    Apple Watch’s hypertension feature may miss some cases, researchers find

    The absence of an alert provides limited reassurance, particularly for older adults or people with an elevated risk of high blood pressure, according to the study’s authors. 

    By • Feb. 19, 2026
  • The logo of the Food and Drug Administration is seen in a close-up view of the agency's website.
    Image attribution tooltip
    Mario Guti via Getty Images
    Image attribution tooltip

    Medline addresses bed fire risk linked to death

    The FDA said hand pendants and cords may overheat, causing the devices to spark, burn, melt, smoke and catch fire.

    By • Feb. 18, 2026
  • Medtronic's Stealth AXiS system.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic nets FDA clearance for robotic spine system

    Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes market share in the $15 billion cranial and spinal technologies sector.

    By • Feb. 18, 2026
  • A picture of Masimo's headquarters building.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Danaher to buy Masimo for $9.9B to boost diagnostics portfolio

    Masimo’s board considered other potential partners before determining Danaher was an “ideal fit,” executives at the patient monitoring company said.

    By • Feb. 17, 2026
  • Professional photo of Jake Leach
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom seeks expanded Medicare coverage of CGMs for Type 2 diabetes

    New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.

    By • Feb. 13, 2026
  • A picture of Siemens Healthineers' headquarters building in Erlangen, Germany.
    Image attribution tooltip
    Courtesy of Siemens Healthineers
    Image attribution tooltip

    Siemens Healthineers, Mayo Clinic partner on neurodegenerative disease, cancer

    An expanded collaboration between the two organizations will focus on prostate cancer and metastatic liver tumors, in addition to certain neurological disorders.

    By • Feb. 13, 2026
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Novocure wins FDA approval to treat pancreatic cancer with electric fields

    Winning approval to target the 15,000 U.S. patients with locally advanced pancreatic cancer is the first step in a broader expansion in the tumor type.

    By • Feb. 13, 2026
  • The CEO of Neurent Medical displays the Neuromark device with laboratory equipment in the background.
    Image attribution tooltip
    Courtesy of Neurent Medical
    Image attribution tooltip

    Neurent raises $74M to commercialize treatment for nasal condition

    The device creates lesions to disrupt nerve signals that drive mucus production.

    By • Feb. 12, 2026
  • A portrait of Melissa Torres.
    Image attribution tooltip
    Permission granted by AdvaMed
    Image attribution tooltip

    AdvaMed names Melissa Torres as new leader for technology and regulatory affairs

    Torres joins the medtech lobby from the FDA’s Center for Devices and Radiological Health, where she was associate director for international affairs.

    By • Feb. 12, 2026
  • Professional photo of Ivan Tornos
    Image attribution tooltip
    Permission granted by Zimmer Biomet
    Image attribution tooltip

    Zimmer plans US salesforce reorganization

    Zimmer Biomet expects the shift of its U.S. salesforce to a more specialized, direct approach will help it better compete in the orthopedics market.

    By • Feb. 11, 2026
  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards focuses on earlier TAVR adoption

    The heart valve specialist reported a second straight quarter of double-digit TAVR sales growth and credited recent study results with driving a “sense of urgency” for treating patients.

    By • Feb. 11, 2026
  • A person wearing gloves hangs a clear bag with fluid on a metal hook.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Baxter cuts roughly 90 jobs at IV solutions plant that recovered from Hurricane Helene

    Hospital demand for IV solutions in the U.S. is lower than before Hurricane Helene, the company said.

    By • Feb. 10, 2026
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    4 takeaways from the 2026 AF Symposium

    Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation treatments, including pulsed field ablation catheters.

    By • Feb. 10, 2026
  • A modern industrial building with beige and white walls and large blue-tinted glass windows. The name “Stryker” is mounted in black letters on the upper portion of the building. A white smokestack protrudes from the roof, and the sky is light and partly cloudy.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Stryker starts limited release of Mako RPS handheld knee robot

    Surgeons interested in robotic technology but wanting a simpler system than existing platforms are the target market for the new device.

    By • Feb. 10, 2026
  • A picture of a medical catheter against a white background.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine

    Abbott and Pulse released their findings at the AF Symposium that wrapped this weekend in Boston.

    By • Feb. 9, 2026
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA breakthrough program starts FY2026 at steady pace

    Orthopedics was the most active area over the second half of 2025, with the FDA issuing 13 breakthrough designations to devices in the therapeutic area.

    By • Feb. 9, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J recalls coil systems used in aneurysm treatment

    Healthcare providers are advised to stop using the devices after a failure to detach was linked with four serious injuries and one death.

    By • Feb. 6, 2026
  • Shipping containers of varying colors stacked on a ship.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    GE HealthCare expects smaller tariff impact in 2026

    After taking a $245 million hit from the levies in 2025, CFO James Saccaro said the company plans more actions to mitigate their effects in 2026, including shifting its supply chain.

    By • Feb. 5, 2026
  • Medtronic's MiniMed 780G
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic wins expanded FDA label for 780G insulin pump

    The 510(k) decision clears the device for use with ultra-rapid-acting insulins from Eli Lilly and Novo Nordisk.

    By • Feb. 5, 2026
  • A tan and black monument sign with bold orange "Optum" lettering and the address "11000 Optum Circle" sits on a grassy lawn with low shrubs in front of a large, modern office building with glass windows and beige panels. Bare trees and a cloudy sky are in the background.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Prices rise at surgery centers acquired by Optum: study

    The full financial impact of the price hikes could exceed $67 million each year in two dozen markets, according to the new study published in Health Affairs.

    By Rebecca Pifer Parduhn • Feb. 4, 2026
  • Illustration of a heart with a metal, coiled wire going into it.
    Image attribution tooltip
    Courtesy of Abiomed
    Image attribution tooltip

    J&J corrects Impella heart pumps over issue linked to 22 serious injuries

    The urgent correction notice is the latest in a series of actions related to the safety of Impella devices.

    By • Feb. 4, 2026